Interleukin-4-mediated signaling pathway

pathway activity — cross-omics
GO:0035771Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Interleukin-4-mediated signaling pathway pathway is significantly associated with the RNA expression of multiple genes, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are SNX20, ARHGAP9, and ZMYND15, each associated with the pathway in up to 4 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Interleukin-4-mediated signaling pathway activity versus SNX20 in GBM (Pearson r = 0.21).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMSNX20 →+0.606+0.454.004.00834
GBMARHGAP9 →+0.600+0.550.001.00233
HNSCZMYND15 →+0.439+0.382.008.00133
HNSCSIGLEC10 →+0.697+0.480.001.00224
HNSCCD226 →+0.633+0.433<.001.00533
HNSCWAS →+0.547+0.391<.001.00133
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0035771 vs SNX20 — GBM

Per-sample scatter of Interleukin-4-mediated signaling pathway activity vs SNX20 in GBM.

Explore this scatter interactively →

Exploration